Aleor Dermaceuticals gets USFDA nod for Testosterone Topical Solution
It is indicated for replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone: Primary hypogonadism and Hypogonadotropic hypoqonadisrn
